Jun 08, 2017 03:57 PM IST | Source: CNBC-TV18

JHS Svendgaard expect to clock 20-30% revenue growth in FY18

In an interview to CNBC-TV18, Nikhil Nanda, MD of JHS Svendgaard Laboratories gave his outlook for the year.

JHS Svendgaard Laboratories manufactures oral and dental products. The stock is trading at a fresh 52-week high and has gained 83 percent so far in FY18.

In an interview to CNBC-TV18, Nikhil Nanda, MD of the company gave his outlook for the year.

We do roughly about 50 percent from toothbrushes and 50 percent from toothpaste currently, said Nanda. Our new toothpaste facility will be completed in the June and shall be operational from July 1.

Our own brand is about 10 percent of the overall sales of the company, he said. We are consciously trying to grow to about 50 percent by 2020, he added.

JHS Svendgaard's current clientele includes Dabur, Patanjali and Amway. The company receives 65 percent of revenue from these three top clients.

We are confident of doing 20-30 percent growth in this financial year, said Nanda.

Watch accompanying video for more details.

tags #Business

Follow us on
Available On